ĐÁNH GIÁ HIỆU QUẢ ĐIỀU TRỊ NGƯỜI BỆNH U LYMPHO TẾ BÀO T/NK NGOÀI HẠCH BẰNG PHÁC ĐỒ SMILE TẠI BỆNH VIỆN CHỢ RẪY
Objective: To describe the clinical and biological characteristics, the complications related to the treatment, and the treatment response of extranodal NK/T cell lymphoma (ENKL) patients treated with the SMILE regimen (steroid, methotrexate, ifosfamide, L-asparaginase/pegaspargase and etoposide) at Cho Ray Hospital.Subjects and methods: A retrospective case series study was conducted at the Department of Hematology, Cho Ray Hospital, from January 2021 to May 2026. Clinical, biological, and treatment characteristics of ENKL patients treated with the SMILE regimen were collected from the electronic medical record software and patient records. Efficacy was assessed according to the Lugano 2014 criteria based on PET/CT scans combined with re-biopsy of suspicious lesions.Results: From January 2021 to May 2026, we collected information on 31 ENKL patients who met the study criteria. The mean age was 44.7 ± 10 years, and the male:female ratio was 2.44:1. The percentages of patients with nasal congestion, facial swelling and B symptoms were 29%, 12.9%, and 45.2%, respectively. Lugano stage IV accounted for 38.7%, and high risk according to PINK-E for 19.4%. Sixteen patients were treated with the modified SMILE regimen. Among the 14 patients evaluated for response after 3 cycles of chemotherapy, the overall response rate and complete response rate were 92.9% and 78.6%, respectively. The most common complication was grade 4 neutropenia, accounting for 93.1%, followed by elevated liver enzymes and hypokalemia, accounting for 90.3% and 76.9%, respectively. With a median follow-up of 12.8 months, the mortality rate was 35.5% (11/31), mainly due to septic shock during bone marrow suppression after chemotherapy.Conclusion: The SMILE regimen for ENKL patients at Cho Ray Hospital achieved promising response rates in patients evaluated for response; however, hematologic toxicity and infection-related death during bone marrow suppression after chemotherapy remain major challenges.
Authors
- Hoang Thi Thuy Ha
- Thái Minh Hiếu Lý
- Dương Bích Trâm Huỳnh
Institutions
- Cho Ray Hospital (VN)
Publication Details
- Journal
- Journal of Clinical Medicine Bach Mai Hospital
- Published
- 2026-11-21
- DOI
- https://doi.org/10.52322/jocmbmh.156.0314
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00